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Abstract
Epidemiological data on staphylococcal scalded skin syndromes (SSSS), including bullous impetigo (BI) and generalized exfoliative syn-
drome (GES), are scarce. To better characterize SSSS and associated Staphylococcus aureus strains, we conducted a retrospective study
of 349 cases collected in France between 1997 and 2007 by the National Reference Centre of Staphylococci. Our results showed a sta-
tionary evolution of SSSS cases, with a heterogeneous distribution of cases in France. Although notification was not exhaustive, we esti-
mated an incidence of 0.56 cases/year/million inhabitants, in accordance with previous studies conducted in France and Europe, with a
median age of 2 years old and sex ratios of 1. A seasonal effect was observed, with a higher GES/BI ratio in autumn compared with
other seasons, which could be explained by the impact of viral co-infection. Genetic analysis of S. aureus strains showed that accessory
gene regulator (agr) 4, exfoliative toxin A (eta) and B (etb) genes, staphylococcal and enterotoxin-like O (selo) gene and agr4 etb selo
profiles were predominantly associated with GES, whereas agr2 eta and agr4 eta selo were more frequently observed with BI. Only one
methicillin-resistant strain was found. Protein A (spa) typing identified two main genotypes: spa clonal complex (CC) 159/sequence-type
(ST) 121 (75%) and spaCC346/ST15 (18%). spaCC159 was mainly associated with agr4 eta etb selo, agr4 eta selo and agr4 etb selo, and
spaCC346 was mainly associated with agr2 eta, suggesting that French SSSS cases are caused by these two main lineages. However, in a
multivariate analysis, only etb was independently associated with GES.
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Introduction
Staphylococcal scalded skin syndrome (SSSS) is a generic
term referring to a group of rare blistering diseases ranging
from generalized diseases (generalized exfoliative syndrome
(GES), Ritter’s disease in newborns) to localized bullous
impetigo (BI) caused by Staphylococcus aureus producing exfo-
liative (or epidermolytic) toxin (ET). To date, four variants
of the toxin have been described: exfoliative toxins A, B, C
and D (ETA–ETD) [1–3]. ETA, ETB and ETD belong to the
serine protease family, whereas there are still doubts con-
cerning ETC because the sequence published in GenBank
(BAA99412) corresponds to an adenylosuccinate lyase [2].
The ETs induce epidermal blistering through the cleavage of
the cell–cell adhesion molecule desmoglein-1, which is only
expressed by keratinocytes in the granular cell layer [4]. ET
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activity is host specific and among ETs only ETA and ETB
exhibit human specificity as the result of a strong cleavage
activity of human desmoglein-1, which explains why only
ETA-producing and ETB-producing strains are epidemiologi-
cally associated with SSSS, and not ETD [4–6].
Only 5% of S. aureus human isolates produce ETA or ETB,
with differences in their prevalence between countries [7].
Previous studies have suggested that ET-producing strains are
mainly associated with a few S. aureus genetic backgrounds, as
defined by phage type, accessory gene regulator (agr) groups
or amplified fragment length polymorphism analysis, but these
genetic backgrounds have not been extensively defined by
‘protein A (spa) typing’ or multilocus sequence typing [8,9].
From an epidemiological point of view, data on SSSS are
scarce in the absence of active survey of the diseases.
The aim of this work was to examine the epidemiology of
SSSS and the microbiological characteristics of ET-producing
strains isolated in France during the last 10 years.
Material and Methods
Cases
All cases of SSSS referred to the National Reference Centre of
staphylococci (CNR-Staph) between 1 January 1997 and 31
December 2007, from different hospitals in France were con-
sidered in the study. The included cases were identified pri-
marily by review of the medical records. GES was diagnosed in
patients with erythroderma progressing within 1–2 days to
spontaneous exfoliation with a positive Nikolsky’s sign and
fever; BI was diagnosed in patients with localized bullous
lesions and exfoliation who were afebrile [7]. A total of 349
cases fulfilling the definition of SSSS were included in this
study, comprising 212 GES cases and 137 BI cases. Data includ-
ing age, sex, date of SSSS diagnosis, geographic localization,
source of the clinical sample where the strain was isolated and
clinical associate diagnosis were collected for each case.
S. aureus isolates
Staphylococcus aureus was isolated from patients with GES by
swab culture of the skin surface or distant sites, such as the
throat, nose, eyes and ears, and blood culture. Isolates from
patients with BI were generally cultured from bullous lesions.
A single isolate was studied when multiple identical isolates
were recovered from the same patient. The S. aureus was
identified as previously described [8].
Strain characterization
A total of 283 strains, corresponding to 167 GES and 116 BI
cases, were selected among 349 strains including 3, 1, 9, 28,
38, 33, 36, 50, 52 and 33 strains isolated in 1997, 1998 and
2000 to 2007, respectively. They comprised a subset of strains
isolated between 1997 and 1999 from Jarraud’s collection (a
random selection of strain isolated between 1985 and 1999) [8]
and all SSSS strains received by the CNR-Staph between 2000
and 2007. Genomic DNA was extracted with a standard proce-
dure. A PCR was used to detect sequences specific for agr and
the following toxin genes as previously described [8,10,11]:
tst, sea, seb, sec, sed, seh, selo, eta, etb, etd, pvl and mecA encod-
ing toxic shock syndrome toxin-1, staphylococcal enterotoxins
A–D and H, staphylococcal enterotoxin-like O, exfoliative tox-
ins A, B and D, Panton–Valentine leukocidin and methicillin
resistance, respectively. Staphylococcal Cassette Chromosome
mec cassette type was determined by DNA microarray (Staphy-
Type kit; Alere Technologies GmBH, Jena, Germany) as previ-
ously described [12]. Typing of spa was also performed as
previously described [13]; spa types were determined using
RIDOM STAPH TYPE software (Ridom GmbH, Mu¨nster, Ger-
many, http://spaserver.ridom.de) [13], and spa types were clus-
tered into clonal complexes (spaCCs) with the integrated
Based Upon Repeat Patterns (BURP) algorithm [14]. User-
definable parameters were set as follows: ‘cluster spa types into
spaCC if cost distances are £4’ and ‘exclude spa types shorter
than five repeats’. Sequence type (ST) was inferred from certain
spa-types as suggested by RIDOM STAPH TYPE software [13].
Statistical analysis
Incidence per million inhabitants was calculated per year on the
average population of the cover area. The average yearly popu-
lation corresponding to the period 1997–2007 was obtained
from the French ‘Institut national de la statistique et des e´tudes
e´conomiques’ (INSEE; http://www.insee.fr/fr/). The number of
observed cases per year was considered a sample over the time
to estimate 95% CI for the number of expected new cases per
year. Taking into account that the occurrence of SSSS is extre-
mely rare, the 95% CI were calculated assuming a Poisson dis-
tribution as previously performed [15]. Chi-square tests were
used to compare proportions. Genetic determinants (toxin
gene, agr type, spaCC) with unequal distribution between GES
and BI were included in a binary multivariate logistic regression
analysis to determine the most influential explanatory variables
for the clinical presentation. All of the analyses were performed
using SPSS software (SPSS Inc., Chicago, IL, USA).
Results
Number and distribution of SSSS cases in France
Between January 1997 and December 2007, we collected
349 cases, including 212 cases of GES and 137 cases of BI.
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The number of cases varied from 10 to 53 per year, with a
non-significant increase in the number of cases during these
10 years (Fig. 1). The mean incidence of SSSS in France was
estimated to be 0.56 cases/year/million inhabitants (95% CI
0.37–0.74; Table 1) with extreme values going to 0.17 (95%
CI 0.01–0.27) cases/year/million inhabitants in 1997 to 0.84
(95% CI 0.63–1.1) cases/year/million inhabitants in 2006.
However, high variation between administrative regions was
observed (1–118 cases), suggesting a non-exhaustive sample
(Table 1). The highest notification was in the Rhoˆne area
(75 cases in 10 years for 1 700 000 inhabitants, that is c.4.4
(95% CI 1.3–7.6) cases/year/million inhabitants), where
CNR-Staph is located. At the regional level, we observed a
homogeneous distribution of SSSS cases per year, except
for the Ile de France region from 2003 to 2005 and the
Aquitaine region in 2005 (see Supplementary material,
Fig. S1).
Characteristics of patients suffering from SSSS
The vast majority of the cases occurred in young patients,
with a median age of 1.8 years for GES (newborn to
81.3 years) and 2.3 years for BI (newborn to 72.3 years).
Only five (2.4%) cases of GES and ten (7.3%) cases of BI
were from patients older than 18 years. Sex ratios were
roughly similar: 0.81 for GES and 1.19 for BI. Of note, 19
(5.4%) cases of SSSS occurred after varicella: nine (4.2%)
GES and ten (7.3%) BI.
Effect of seasons on SSSS occurrence
We observed variations in the number of notified cases of
SSSS between seasons. The number of SSSS cases increased
during the summer for both GES and BI. However, the GES/
BI ratio was significantly higher in autumn compared with
other seasons (p 0.021; Fig. 2).
Isolation sites of SSSS strains
Of the 212 cases of GES, eta- and/or etb-positive strains
were isolated from skin lesions in 119 (56.1%) cases; the
throat, nose, eyes or ears in 75 (35.4%) cases; and the stool
in two (0.9%) cases. In 13 (6.1%) cases, toxigenic strains
were isolated from deep sites, such as blood cultures (eight
cases, 3.8%) and peritoneal fluid. The sampling site was not
indicated for three (1.4%) patients. In the 137 BI cases, eta-
and/or etb-positive strains were isolated from skin lesions in
113 (82.5%) cases and the throat, nose, eyes or ears in 23
(20.4%) cases. Only one (0.7%) sampling site was not known.
Toxin profiles of French SSSS strains
The toxin gene profile was determined in a subset of 283
strains. These strains were all positive for the production of
at least one exfoliative toxin: 36% of strains carried eta
alone, 10% carried etb alone and 54% carried both eta and
etb. No strain carried the etd gene (Table 2). Allelic determi-
nation of agr showed that 76% of strains were agr4, 22%
were agr2, 2% were agr3 and one strain was agr1. Among
FIG. 1. Distribution of the number of cases of staphylococcal scalded skin syndrome (SSSS), generalized exfoliative syndrome (GES) and local-
ized bullous impetigo (BI) per year and per year estimated incidence of SSSS cases according to the French National Reference Centre of staphy-
lococci notifications from 1997 to 2007. Annual estimated incidences of SSSS cases (dotted curve and secondary scale in grey) were calculated
with the French population data provided by the French ‘Institut National des Statistiques et des Etudes Economiques’ and available from http://
www.insee.fr/fr/themes/tableau.asp?reg_id=0&ref_id=NATnon02145.
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genes encoding superantigenic toxins, 80% of isolates were
positive for selo and 4% were positive for seb, whereas sea
and sed were detected only once, no strain contained tst or
sec, and pvl was detected in two isolates. The most frequent
gene associations were agr4 eta etb selo (50%), followed by
agr2 eta (17%), agr4 eta selo (12%) and agr4 etb selo (10%).
Spa types of French SSSS strains and their sequence type
assignments
Spa typing was successfully performed on 280 of the 283
S. aureus isolates and led to the classification of 277 strains
with 40 different spa types distributed in five main spaCC
clusters plus singletons (Tables 2 and 3). The number of iso-
lates associated with each spaCC cluster ranged from 2 to
212 isolates. Among them, 75% belonged to spaCC159
(ST121), and 18% belonged to spaCC346 (ST15). For the
other spaCCs, no founder was identified. The distribution of
spaCCs remained stable during the 10 years of the survey.
Methicillin resistance of French SSSS strains
Only one strain isolated from a post-varicella GES and charac-
terized by a genetic profile of agr3 eta spa t186 (ST88) was
mecA positive, showing an IV-SSCmec cassette type (Table 2).
Analysis of potential associations between SSSS clinical pre-
sentation, toxin gene contents, and spa type
When we compared the distribution of genes between iso-
lates from patients with GES and BI, the distribution of eta,
TABLE 1. Estimated incidence of staphylococcal scalded
skin syndrome (SSSS) cases in France according to the
French National Reference Centre of staphylococci notifica-
tions from 1997 to 2007









Alsace 6 1 837 087 0.33
Aquitaine 29 3 177 625 0.91
Auvergne 9 1 341 863 0.67
Brittany 7 3 149 701 0.22
Burgundy 17 1 638 588 1.04
Centre 3 2 531 588 0.12
Champagne-Ardennes 4 1 338 004 0.30
Corse 0 302 966 0
Franche-Comte´ 3 1 163 931 0.26
Ile de France 43 11 659 260 0.37
Languedoc-Roussillon 4 2 581 718 0.15
Limousin 10 740 743 1.35
Lorraine 12 2 346 361 0.51
Lower Normandy 6 1 467 425 0.41
Midi-Pyre´ne´es 9 2 838 228 0.32
Nord Pas de Calais 21 4 024 490 0.52
Pays de Loire 6 3 510 170 0.17
Picardy 5 1 906 601 0.26
Poitou-Charentes 6 1 752 708 0.34
Provence Alpes Coˆte d’Azur 20 4 882 913 0.41
Rhoˆne-Alpes 118 6 117 229 1.93
Upper Normandy 6 1 825 667 0.33
Overseas regions 5 2 013 445 0.25
Total 349 64 148 311 0.54
aNumber of inhabitants in 2008, as provided by the French Institut National des




FIG. 2. Distribution of staphylococcal scalded skin syndrome pre-
sentations over the seasons. BI, localized bullous impetigo; GES, gen-
eralized exfoliative syndrome. p calculated using a chi-square test.
TABLE 2. Distribution of toxin and spa clusters among
Staphylococcus aureus isolates from generalized exfoliative
syndromes (GES) and bullous impetigo (BI)
Genes/gene association GES (n = 167) BI (n = 116) pa
Genes
etab 142 (85) 112 (97) 0.001
etbb 127 (76) 54 (47) <0.001
etdb 0c 0c nd
sead 1 (0.6) 0 nd
sebd 7 (4) 4 (3.4) nd
sedd 1 (0.6) 0 nd
seloe 146 (87) 82 (71) 0.001
pvlf 2 (1.1) 0 nd
mecAg 0 1 nd
agr1h 0 1 (0.9) nd
agr2h 24 (14) 38 (33) <0.001
agr3h 3 (1.8) 2 (1.7) nd
agr4h 140 (83) 75 (65) <0.001
spaCCi
spaCC159 141 (84.4) 71 (61.2) <0.001
spaCC346 16 (9.6) 34 (29.3) <0.001
spa209/4812 3 (1.8) 6 (5.2) nd
spa186/692 3 (1.8) 2 (1.7) nd
spa2166/8692 1 (0.6) 1 (0.9) nd
spa type using RIDOM STAPH TYPE software and spaCC were determined using
the integrated Based Upon Repeat Patterns (BURP) algorithm as described in
Material and methods. Sequences specific for agr1–4 and the toxin genes tst,
sea, seb, sec, sed, seh, selo, eta, etb, and lukS-PV-lukF-PV were detected by poly-
merase chain reaction. Percentages were calculated in comparison to total num-




beta, etb and etd: genes encoding exfoliative toxins A, B and D.
cetd detection was performed on only 278 isolates.
dsea–d, genes encoding staphylococcal enterotoxin A–D.
eselo, genes encoding staphylococcal enterotoxin-like O.
fpvl, gene encoding Panton–Valentine leukocidin.
gmecA, gene encoding resistance to methicillin.
hagr, allele of accessory gene regulator.
jspaCC, clonal complexes determined by spa typing.
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etb, selo, agr2 and agr4 differed significantly (Table 2). Briefly,
etb, selo and agr4 were more frequent in isolates from GES
than BI; however, the opposite was found for eta and agr2.
When we compared associations between gene profiles and
the type of diseases, we observed similar results: agr4 eta etb
selo and agr4 etb selo gene profiles were predominantly
TABLE 3. Spa type, agr type and toxin gene profile of Staphylococcus aureus isolates from staphylococcal scalded skin syn-
drome
Cluster (spaCCa) spa type agrb Genes encoding toxins Total GES (n = 167) BI (n = 116)
1 (spaCC159) 159 4 etac, etbc, sebd, seloe 2 1 1
eta, etb, selo 82 49 33
eta, selo 15 9 6
etb, seb, selo 1 1 0
etb, selo 17 15 2
2 eta, etb, selo 1 1 0
eta, etb 1 1 0
eta, selo 1 0 1
eta 2 1 1
162 4 eta, etb, selo 1 0 1
eta, selo 1 1 0
171 4 eta, etb, selo 17 12 5
eta, selo 3 1 2
etb, selo 1 1 0
269 4 eta, etb, selo 2 2 0
eta, selo 2 0 2
2 eta 1 1 0
272 4 eta, etb, selo 3 3 0
eta, seb, selo 1 1 0
eta, selo 2 0 2
284 4 eta, etb, selo 3 2 1
408 4 eta, etb, selo 4 3 1
605 2 eta 1 1 0
645 4 eta, etb, selo 10 10 0
eta, seb, selo 1 0 1
eta, selo 2 0 2
etb, selo 4 3 1
659 4 eta, etb, selo 3 3 0
eta, selo 1 1 0
2 eta 1 0 1
940 4 etb, selo, pvlf 1 1 0
1077 4 etb, selo 1 1 0
1260 4 eta, etb, selo 1 0 1
2 eta, selo 1 1 0
1425 4 eta, etb, selo 3 3 0
2019 4 eta, selo 1 0 1
2086 4 eta, selo 1 1 0
2155 4 eta, etb, seb, selo 6 4 2
eta, etb, selo 1 1 0
3241 4 eta, selo 1 0 1
4151 4 etb, selo 1 1 0
4390 4 eta, etb, selo 1 1 0
8194 4 eta, etb, selo 1 0 1
etb, selo 1 0 1
8639 4 eta, etb, selo 1 0 1
8688 4 etb, selo 1 1 0
8762 4 eta, etb, selo 1 1 0
8822 4 eta, etb, selo 2 2 0
2 (spaCC346) 84 4 eta, etb, selo 3 1 2
eta, selo 1 1 0
2 eta, selo 1 0 1
eta 29 12 17
97 2 eta 1 0 1
254 2 eta 5 1 4
346 4 eta 1 0 1
2 eta, selo 1 0 1
eta 3 0 3
1 eta, selo 1 0 1
360 2 eta 1 0 1
1875 2 eta 1 0 1
1877 2 eta 2 1 1
3 (spaCC ND) 209 4 eta, selo 1 0 1
2 eta, selo 6 2 4
eta 1 0 1
4812 2 eta, selo 1 1 0
4 (spaCC ND) 186 4 eta, etb, selo 1 1 0
3 eta 2 2 0
692 3 eta 2 0 2
5 (spaCC ND) 2166 4 eta, etb, selo 1 1 0
8692 4 eta, etb, selo 1 0 1
NC 67 1 eta, selo 1 1 0
3623 3 eta, sea, selo, pvl 1 1 0
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associated with GES, whereas for BI, the predominant gene
profiles were agr2 eta and agr4 eta selo. Clinical presentation
also depended of the spa type: spaCC159 was more frequent
in isolates from GES than BI, whereas it was the opposite
for spaCC349. Gene profiles of the strains were also linked
to the spa type. Genotypes agr4 eta etb selo, agr4 etb selo,
and agr4 eta selo were mainly associated with spaCC159,
whereas genotype agr2 eta was predominantly associated
with spaCC346. However, in binary logistic regression analy-
sis including spaCC groups, agr alleles, eta, etb and selo, only
etb was independently associated with GES (p 0.01).
Discussion
We have retrospectively examined the epidemiology of 349
cases of SSSS, corresponding to 212 cases of GES and 137
cases of BI, that were reported to CNR-Staph from 1997 to
2007 by medical laboratories distributed throughout France.
The number of cases remained stable during these 10 years,
except for the Ile de France region from 2003 to 2005 and
the Aquitaine region in 2005, which corresponded to two
outbreaks in maternity wards, as previously reported
[16,17]. Although SSSS is not a notifiable disease in France,
our results allowed us to establish a mean incidence of SSSS
cases based on spontaneous reporting by French microbio-
logical laboratories of 0.56 (95% CI 0.37–0.74) cases/year/
million, in accordance with previous estimates (0.30 and 0.35
during 1994–1997 and 1998–2000, respectively) and an esti-
mation of 0.13 in Germany [15,18,19]. However, a large dis-
crepancy in the notification between French regions is
observed, suggesting many under-declarations of cases to
CNR-Staph. Incidence estimation in the Rhoˆne area, where
declarations are the highest, was 4.4 cases/year/million. This
value is closer to the incidence recently described in the
Czech Republic from a 15-year survey, with an average inci-
dence of 25.11 cases/million/year in children under 1 year
old, which corresponds to 2.53 cases per million inhabitants
per year [20]. However, SSSS, notably GES, can be difficult
to diagnose on clinical signs with the lack of adapted micro-
biological samples and strain isolation. In accordance to simi-
lar SSSS surveys based on S. aureus strain isolations, our
study is not exhaustive suggesting a higher incidence of SSSS
cases in France than measured. Prospective surveys, including
mild SSSS forms and based on clinical and histological data,
should be performed. When we examined variations in the
GES/BI ratio between seasons, most of the SSSS cases were
observed during the summer. However, we observed a sig-
nificantly higher ratio of GES/BI in autumn than other sea-
sons (Fig. 2). Autumn shows a high incidence of viral upper
respiratory tract infections in France caused by rhinovirus,
parainfluenza virus, enterovirus, respiratory syncytial virus
and influenza virus [21]. Because GES is usually accompanied
by non-specific virus-like prodromal signs and symptoms in
the upper respiratory tract, such as coryza, viral infections
could contribute to the development of GES in young
patients colonized by S. aureus ET-producing strains. We
hypothesize that in ET-producing strain carriers, a virus
infecting the upper respiratory tract of a young patient alters
the epithelium and stimulates S. aureus proliferation, trigger-
ing ET production and diffusion in the body. Cooperation
between influenza and parainfluenza viruses, and S. aureus
has been previously described in pneumonia [22–24]. More-
over, we previously conducted a retrospective survey on
S. aureus superinfections during varicella [25]. Exfoliative
toxin genes were the second major toxinic factor detected
in S. aureus isolates, suggesting that a specific survey should
be performed to confirm the involvement of a virus in the
pathophysiology of SSSS.
Regarding patient data linked to strains, the most cases
occurred in young children. Only five GES and ten BI cases
were observed in adult patients without renal dysfunction or
immunosuppression, two main factors classically reported to
be associated with SSSS in adults [26]. The vast majority of
GES cases occurred in patients with only nasal colonization
by S. aureus ET-producing strains and no focal infection; the
TABLE 3. Continued.
Cluster (spaCCa) spa type agrb Genes encoding toxins Total GES (n = 167) BI (n = 116)
NT 4 eta, selo 2 0 2
NT 4 etb, selo 1 1 0
spa type and spaCC were determined using the integrated Based Upon Repeat Patterns (BURP) algorithm as described in Material and methods. Sequences specific for agr1–
4 and the toxin genes tst, sea, seb, sec, sed, seh, selo, eta, etb, and lukS-PV-lukF-PV were detected by PCR.
GES, generalized exfoliative syndrome; BI, bullous impetigo; ND, not described; NC, not clustered; NT, not typeable.
aspaCC, clonal complexes determined by spa typing.
bagr, allele type of accessory gene regulator.
ceta, etb, genes encoding exfoliative toxins A and B.
dseb, gene encoding staphylococcal enterotoxin B.
eselo, gene encoding staphylococcal enterotoxin-like O.
gpvl, gene encoding Panton–Valentine leukocidin.
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exceptions were SSSS cases after superinfection of varicella,
peritoneal infection and endocarditis.
In contrast to Japan, Switzerland and Taiwan [27–29], we
did not observe the emergence of methicillin-resistant S. aur-
eus (MRSA) -associated exfoliative toxin genes, with only one
MRSA strain being agr3 spa t186 (ST88) with an IV-SSCmec
cassette type. Although epidemiological data on MRSA iso-
lated from SSSS were scarce, ST88, ST89 and ST91 have
recently been linked to MRSA associated with BI in Japan
[29,30]. Our strain belongs to one of these main MRSA
clones and could be an imported Japan strain; however, no
clinical data sustain this hypothesis. For decades, the majority
of S. aureus strains responsible for SSSS in Europe have
belonged to phage group II, particularly types 71 and 55/71
[26], agr4 or agr2 and the specific amplified fragment length
polymorphism phylogenetic groups AF1 agr4 or AF2 agr2
[8,9]. Our results showed that 75% of S. aureus strains iso-
lated from SSSS were agr4 spaCC159 (ST121), and 18%
were agr2 spaCC346 (ST15). These strains correspond to
AF1 agr4 and AF2 agr2, respectively. Because we did not
perform phage typing, we do not know to which phage type
they belonged. ST121 clones have previously been associated
with skin and soft tissue infections involving Panton–Valen-
tine leukocidin-positive methicillin-susceptible S. aureus
(MSSA) strains in Europe and China [31]. Sporadic ST121
strains with exfoliative genes, MSSA and, more recently,
MRSA have been described in paediatric patients in Portugal
[32]. However, a recent multicentre Japanese study on
MRSA strains responsible for BI noted that ST121 seemed
to be the most common ST for exfoliative-positive MSSA
[30]. Moreover, data describing ST15 strains are scarce.
MRSA ST15 strains have been found in Italy, and ST15 MSSA
strains with spa type t084 from spaCC346 have been simi-
larly observed in China and Africa, but no data regarding ex-
foliative toxins or associations with specific clinical signs are
available [33,34]. Only the previous Japanese study found
three isolates of ST15 MSSA in addition to an ST8 MRSA in
BI lesions [30]. Hence, our work is the first study that
clearly associates, on a large collection of strains, spaCC159
(ST121) and spaCC346 (ST15) with SSSS and, more pre-
cisely, spaCC159 (ST121) with GES and spaCC346 (ST15)
with BI. In fact, the genetic background of S. aureus is not
enough to explain the occurrence of SSSS because ETA and/
or ETB are necessary to induce SSSS. Because eta and etb
are carried by mobile genetic elements [26,35], it is possible
that the spaCC159 (ST121) and spaCC346 (ST15) back-
grounds are favourable for their acquisition or expression.
Moreover, we previously showed that eta was associated
with BI, whereas etb was associated with GES [36]. The
strength of this association was confirmed in our multivariate
analysis, which demonstrated that only etb was independently
associated with GES. Finally, we confirmed the lack of associ-
ation between SSSS and ETD, with no etd-positive strain, as
previously described in 2006 and confirmed by Japanese and
Czech studies [5,6,37]. However, the possibility of overlook-
ing an SSSS-like disease caused by an etd-positive strain could
not be excluded because the clinical symptoms induced by
these isolates may be milder than those caused by eta-posi-
tive or etb-positive strains and not notified to CNR-Staph.
In conclusion, during the last 10 years, we observed the
stability of epidemiological parameters of SSSS and S. aureus
lineages involved in these diseases, including spaCC159
(ST121) and spaCC346 (ST15) carrying eta or etb. We con-
firmed that the generalized form of SSSS is linked to the
presence of etb, whereas the relative increase in GES in
autumn suggests that autumnal upper respiratory tract infec-
tions by a viral agent may trigger ET effects in S. aureus ET-
producing carriers.
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